Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) posted its quarterly earnings data on Monday. The pharmaceutical company reported $4.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.61 by $1.15, Briefing.com reports. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.58 billion. Vertex […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) released its quarterly earnings results on Monday. The pharmaceutical company reported $4.76 earnings per share for the quarter, topping analysts’ consensus estimates of $3.61 by $1.15, Briefing.com reports. The firm had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.58 billion. Vertex Pharmaceuticals […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) issued its quarterly earnings results on Monday. The pharmaceutical company reported $4.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.55 by $0.53, RTT News reports. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.50 billion. Vertex […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Rating) announced its quarterly earnings data on Monday. The pharmaceutical company reported $3.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.51 by $0.54, Briefing.com reports. Vertex Pharmaceuticals had a return on equity of 27.78% and a net margin of 37.20%. The business had revenue of […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Rating) released its earnings results on Monday. The pharmaceutical company reported $3.05 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.48, Briefing.com reports. Vertex Pharmaceuticals had a return on equity of 27.78% and a net margin of 37.20%. The company had revenue of $2.37 billion […]